In order to comply with POJK provisions No.34/2014, the nomination and remuneration functions are carried out by the Company’s Board of Commissioners.
The duties and responsibilities of the Board of Commissioners in the Nomination and Remuneration function are as follows:
The membership composition of the Nomination and Remuneration Committee is as follows:
|Structure of the Nomination and Remuneration Committee|
|Anggota||:||Rohni Cahaya Manik|
In accordance with Article 7 paragraph (1) POJK 34/2014, each member of the Nomination and Remuneration Committee must act independently in carrying out their functions. What is meant by acting independently has been described in the Explanation of Article 7 paragraph (1) POJK 34/2014, namely carrying out duties and responsibilities in accordance with the goals and needs of the company in a professional and independent manner, and not influenced by intervention from other parties. Thus, independent action must be interpreted as professional, independent and objective.
The work experience of the Nomination and Remuneration Committee is as follows:
|2021 – sekarang||Komisaris Independen||PT Arna Cahaya Medika tbk|
|2019 – sekarang||Direktur Utama||PT Eska Investama Presisi|
|2021 – sekarang||Direktur||PT Marian Anugrah Akua|
|2021 – sekarang||Presiden Komisaris||PT Arna Cahaya Medika tbk|
|2020 – sekarang||Direktur Utama||PT Heksa Lingkar Diagnostiks|
|2011-2020||Direktur Keuangan||PT Biosains Medika Indonesia|
Meetings of the Nomination and Remuneration Committee members are held at least 1 (one) time every 4 (four) months, with a minimum attendance rate of 2 (two) members. Until the Prospectus was published, there had not been a Nomination and Remuneration Committee Meeting held in connection with the newly formed Nomination and Remuneration Committee.
In the context of supervising operational activities and the use of the Company’s assets, all management and employees of the Company have their respective functions, roles and duties in improving the quality and implementation of an internal control system that is carried out effectively and sustainably, which includes oversight of operational activities at the head office Company and each branch in the region.
The implementation of internal control is implemented through clear policies, regulations and procedures so that it can be empowered in carrying out the internal control function while minimizing risks that may arise. Programs implemented by the Company related to internal control include supervisory activities and strategic activities, which among others consist of:
The Company realizes that the internal control measures that have been carried out so far do not guarantee that there is no risk of abuse or other forms of risk. However, the Company’s Management is committed to always ensuring and improving the internal control system.